Skip to main content

New Products

  • Sparkling ICE adds two new flavors

    PRESTON, Wash. — TalkingRain has added two new flavors to its Sparkling ICE brand of zero-calorie beverages. The new Cherry Limeade and Strawberry Watermelon flavors debuted in January, expanding the brand’s flavor portfolio to 11 zero-calorie options.

  • Doxercalciferol now available from Roxane Labs

    COLUMBUS, Ohio — Roxane Labs on Tuesday announced the introduction of doxercalciferol capsules, available in strengths of 0.5-mcg, 1-mcg, and 2.5-mcg in 50-count bottles for immediate shipment to wholesalers and pharmacies across the nation.  

    Doxercalciferol is used to lower elevated parathyroid hormone levels in patients who undergo kidney dialysis. Roxane Labs’ doxercalciferol capsules is AB Rated in the Food and Drug Administration Orange Book to Hectorol (doxercalciferol) capsules, 0.5-mcg, 1-mcg, and 2.5-mcg.

  • Report: Florida lawmakers eye telemedicine

    NEW YORK — Lawmakers in Florida are looking into ways to ease regulatory limitations for telemedicine in an effort to increase access to care and create “a fertile ground” for the technology to be used, according to a local report.

  • New device aims to keep Rx drugs out of the 'wrong hands'

    NOVATO, Calif. — 4ThoughtProducts has announced the release of Pill Pod, a new safety device that serves as a "keyless" drug lock box for use in the home.

  • Janssen Biotech: Second indication won for cancer drug Imbruvica

    HORSHAM, Pa. — Janssen Biotech on Wednesday announced the Food and Drug Administration has approved Imbruvica (ibrutinib) capsules for the treatment of patients with chronic lymphocytic leukemia who have received at least one prior therapy. Imbruvica was first approved in November 2013 for the treatment of patients with mantle cell lymphoma who have received at least one prior therapy. Both indications are based on an overall response rate. An improvement in survival or disease-related symptoms has not been established.

  • Merz North America launches Mederma PM

    GREENSBORO, N.C. — Merz North America recently launched Mederma PM, a new one-of-a-kind scar cream formulated to work at night, when skin naturally regenerates faster.  

    Mederma PM Intensive Overnight Scar Cream is formulated to complement this nighttime activity with Tripeptol, a skin-nourishing complex with peptides, collagen and antioxidants to promote healthy-looking skin and help skin fight free radical damage. 

  • Pharmacy automation provider Kirby Lester goes live with new online store

    LAKE FOREST, Ill. — Pharmacy automation provider Kirby Lester on Thursday went live with its new online store

    Kirby Lester maintains one of the largest markets of automatic tablet/capsule counter sales in the United States. 

  • Reckitt Benckiser talks about Mucinex, Airborne line extensions

    SLOUGH, England — Reckitt Benckiser has line extended its Mucinex franchise into the year-round allergy sector with Mucinex Allergy, Heather Allen, Reckitt Benckiser EVP category development, told analysts Wednesday. 

    "Super fantastic launch in the U.S.," she said. "Allergy is a $2.5 billion market in the U.S. More than 75% of Mucinex users also take an allergy treatment, and now, we're able to offer them Mucinex Allergy, maximum strength, non-drowsy antihistamine, acts fast and lasts for 24 hours."

X
This ad will auto-close in 10 seconds